Stockreport

With 43% stake, Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) seems to have captured institutional investors' interest [Yahoo! Finance]

Y-mAbs Therapeutics, Inc.  (YMAB) 
Last y-mabs therapeutics, inc. earnings: 11/13 04:01 pm Check Earnings Report
PDF The top 9 shareholders own 53% of the company Insiders have been selling lately If you want to know who really controls Y-mAbs Therapeutics, Inc. ( NASDAQ:YMAB ), t [Read more]